GlassScriptPhysician profile
Kimberly D Richardson
NPI 1952407553
$2,831.85
in general payments reported to CMS, 2019-2025
36 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $407 · 2023: $658 · 2024: $536 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,214.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $379.05 | 2022-2025 | Evenity, Otezla, Repatha |
| Novo Nordisk INC | $295.20 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $273.92 | 2021-2025 | |
| Glaxosmithkline, LLC. | $243.49 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $215.56 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $193.89 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $130.80 | 2024-2025 | |
| Boston Scientific Corporation | $128.98 | 2023-2024 | Watchman Flx |
| Radius Health, INC. | $76.75 | 2022-2025 | Tymlos |
| Almatica Pharma LLC | $73.11 | 2025 | Teriparatide, Loreev Xr |
| Lundbeck LLC | $66.90 | 2023-2025 | Rexulti |
| Corcept Therapeutics | $65.11 | 2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $54.00 | 2023 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $53.42 | 2022 | |
| Merck Sharp & Dohme LLC | $46.93 | 2022-2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $44.10 | 2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.48 | 2021 | |
| Sumitomo Pharma America, INC. | $41.70 | 2024-2025 | Gemtesa |
| Currax Pharmaceuticals LLC | $40.52 | 2021-2025 | Contrave |
| Dexcom, INC. | $36.68 | 2021-2023 | Dexcom G6 Transmitter |
| Globus Medical, INC. | $34.03 | 2025 | Senza |
| Exact Sciences Corporation | $29.92 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $27.10 | 2021-2022 | |
| Grt US Holding, INC. | $25.08 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.78 | 2025 | Evkeeza |
| Abbott Laboratories | $20.72 | 2021 | |
| Ge Healthcare | $19.62 | 2023 | |
| Sunovion Pharmaceuticals INC. | $19.56 | 2022 | |
| Insulet Corporation | $18.12 | 2022 | |
| Grifols USA, LLC | $17.82 | 2024 | Prolastin-C Liquid |
| Daiichi Sankyo INC. | $17.54 | 2021 | |
| Inogen, INC. | $17.31 | 2025 | |
| Eisai INC. | $16.44 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.37 | 2023 | Gvoke Hypopen |
| Kowa Pharmaceuticals America, INC. | $14.85 | 2021 | |
| Medtronic, INC. | $14.00 | 2025 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.